About David Moadel

David Moadel has provided compelling content – and crossed the occasional line – on behalf of Crush the Street, Market Realist, TalkMarkets, Finom Group, Benzinga, and (of course) InvestorPlace.com. He also serves as the chief analyst and market researcher for Portfolio Wealth Global and hosts the popular financial YouTube channel Looking at the Markets.

David Moadel proudly serves as the Chief Analyst and Opportunity Researcher for Portfolio Wealth Global as well as a financial writer for InvestorPlace.com. David is also active on multiple social media platforms, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. His YouTube channel educates and informs a loyal crowd of followers on topics ranging from cryptocurrencies to stocks, options, precious metals, bonds, futures, and other areas of finance. With a master’s degree in education and decades of investing experience, David has the financial know-how and a passion for teaching that has boosted the bottom line of countless clients. Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.


Recent Articles By David Moadel

: TDOC |  News, Ratings, and Charts

After a Rough Year, It's Time to Reconsider Teladoc Health

As Teladoc Health (TDOC)expands to whole-person virtual care, its stock should provide healthy returns.
: DIDI |  News, Ratings, and Charts

It's Just One Awful Update After Another for DiDi Global

Don't try to be a hero with DiDi Global (DIDI) as the downward spiral is likely to continue.
: COIN |  News, Ratings, and Charts

Log Onto a Metaverse-Facing Crypto Platform with Coinbase Global

While connectivity issues need to be addressed, a bold venture into virtual worlds should boost investors' confidence in Coinbase Global (COIN) stock.
: CRSP |  News, Ratings, and Charts

CRISPR Therapeutics Is One of Today's Best Biotech Value Investments

Don't let the downtrend in CRISPR Therapeutics (CRSP) stock fool you, as the company is still making headway in advancing potentially life-changing therapeutics.
: FSR |  News, Ratings, and Charts

Go From Zero to 60 with a Still-Early-Stage Stake in Fisker

Admittedly, it took a long time for Fisker (FSR) to unveil its all-electric SUV. With that event now completed, FSR stock is prepped for a rally.
: BKKT |  News, Ratings, and Charts

Bakkt Is a Worthy Crypto-Centric Holding, but Watch for Bottom-Line Results

While they can celebrate a recent deal with Mastercard, Bakkt (BKKT) stockholders will need to keep a close watch on the company's net earnings.
: LUV |  News, Ratings, and Charts

Southwest Airlines Shareholders Should Brace for Turbulence

Even as the incoming CEO boasts about recent bookings figures, Southwest (LUV) could buckle under the pressure of flight cancellations
: SOFI |  News, Ratings, and Charts

$25 Is On Tap for SoFi Technologies as Analysts Pound the Table

There's high praise going around for SoFi (SOFI) as the company challenges traditional, outdated models of consumer finance.
: XPEV |  News, Ratings, and Charts

$57 Price Target Could Be Just the Beginning for XPeng

Not everybody is enamored with Chinese stocks right now, but investors should consider investing in electric vehicle manufacturer XPeng (XPEV). Here’s why...
: RKLB |  News, Ratings, and Charts

Planned Launches Should Add Fuel to Rocket Lab USA

Rocket Lab USA (RKLB) stock fell almost as quickly as it rose, but November should bring fresh space missions as well as higher share prices.
Page generated in 0.7491 seconds.